Clinical Trial Update: A Study to Assess the Safety of Brexanolone in the Treatment of Adolescent Female Participants With Postpartum Depression (PPD) [Phase 3]

View source ↗

Summary

The update reports the completion of a Phase 3 trial assessing the safety of brexanolone for postpartum depression in adolescent female participants, with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Depression

Drugs mentioned

• Zulresso (brexanolone)

Snippet

Sponsor: Supernus Pharmaceuticals, Inc. | Conditions: Post Partum Depression | Phase 3 | Status: COMPLETED | Results posted: 2022-08-11